The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
There is a number of mechanisms of desensitization including: loss of receptor function through a decrease in receptor-coupled signaling components (e.g., G-proteins)
It produces relatively fast visible changes - cell turnover accelerates, the skin resurfaces, and improvements in texture and tone become noticeable within weeks
Transparent communication about potential risks fosters trust with patients and upholds professional standards
Individuals with lumbar spinal stenosis seek education and care focused on self-managementresults of focus groups among participants enrolled in a randomized controlled trial
This application supports natural lip volume and definition over time, offering a non-invasive alternative to immediate plumpers